Imatinib mesylate (Glivec) pre-treatment does not have a negative effect on outcome of allogenic hematopoietic stem cell transplantation in Philadelphia-positive leukemias.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples